Actualités

See how these popular developed and emerging markets ETFs stack up on fees, performance, and risk profiles.

Investors named Johnson & Johnson, Merck, Pfizer, AbbVie, Eli Lilly and Bristol Myers as possible bidders.

Circle remains the single-best way to get exposure to the $300 billion stablecoin industry.

Demand for memory chips to power AI workflows has led to surging prices in memory chip stocks like Micron.

Investors will watch Tesla's updates on margins, cash flow, Cybertruck, FSD 15, and Optimus.

After all, those official figures probably won't be made public for weeks yet.

Why opt for speculation when you could grab a 6.3% dividend yield that's been paid for 127 years in a row?

Trump Media & Technology Group Corp. (NASDAQ:DJT) rallied by 13.1 percent week-on-week, as investors loaded portfolios amid the revenue prospects from a plan to sell fast access to President Donald Trump’s market-moving posts. In a statement earlier in the week, Trump Media & Technology Group Corp. (NASDAQ:DJT) said that the sale of real-time access is […]

J&J has more than 28 sources of blockbuster revenue.

Maybe you should, too.

Netflix shares sank yet again after it reported its second-quarter results.

AMD looks like a buy ahead of its Advancing AI event.

As countries around the world drastically expand nuclear energy capacity, these two stocks could be huge winners.

Venture Global climbed by 12.7 percent week-on-week, as investors rotated their portfolios into energy stocks amid the surging prices of oil and gas driven by escalating geopolitical tensions. As of Friday, Bloomberg data showed that August Henry Hub natural gas futures traded up by 1.85 percent to $2.91 amid concerns over tighter global gas supplies. […]

They can help stabilize your portfolio in these otherwise volatile times.

AI data centers are rewriting the utility sector's playbook, and four ETFs are jockeying for position as the power grid strains to keep up. Picking the wrong one could mean trading income stability for concentrated bets on a theme that may already be priced in.

Will Musk's "dogged determination" help Tesla beat expectations?

Sandisk is an early candidate for stock of the year.

Apple is riding a wave of momentum led by strong sales and a different AI approach.

One of the newest stocks added to the Berkshire Hathaway investment portfolio is Alphabet. While the position started towards the end of Warren Buffett’s time as CEO of Berkshire, the legendary investor wants people to know he gets the credit...

Geopolitical tensions in the Middle East have escalated in recent days, reviving concerns about oil prices, inflation, and the global economic outlook. Although the uncertainty has added another source of volatility, the S&P 500 remains within 2% of its all-time high, suggesting investors expect the broader economic impact to remain contained.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Sma

One carries a $4.9B net loss and negative free cash flow; the other posts steady 10%+ margins and positive cash generation.

Bitcoin will thrive, regardless of what happens to the CLARITY Act.

Most active large-cap funds quietly bleed investors through bloated fees and closet indexing, but T. Rowe Price built TCAF to break that pattern entirely. Whether it actually does depends on a tradeoff most investors never stop to consider.

The AI race is far from over.

Apple just closed at a record high after a monster run, but the real question is whether the forces driving it higher are durable enough to carry the stock through a gauntlet of legal battles, insider selling, and a looming earnings report that could change everything.

Every headline says Google is hemorrhaging its best AI minds to Anthropic and OpenAI, and that narrative has created one of the most exploitable gaps between fear and reality in the market right now.

DePuy Synthes, part of Johnson & Johnson MedTech, has acquired spine surgery company Expanding Innovations, adding new expandable interbody technologies to its portfolio. Johnson & Johnson has received FDA approval for its Dual Energy THERMOCOOL SMARTTOUCH SF Platform in electrophysiology, expanding its ablation technology offering. For investors watching Johnson & Johnson, ticker NYSE:JNJ, these MedTech moves arrive with the stock at $253.04 and a value_score of 2. The company has recorded...

An endorsement from Buffett makes the Alphabet buy case even more compelling.

Micron just posted one of the most explosive quarters in semiconductor history, yet the stock has cratered nearly 14% in a single week as three distinct threats converge on the memory giant. Whether this selloff is a gift or a warning depends entirely on which scenario plays out next.